Concepedia

Author

Pelin Tokalı

Kafkas University

Also Known As

Furkan Çakır, Pelin Tokalı, Tokalı, Pelin

13

Publications

235

Citations

7

H-Index

10

Concepts

All Affiliations

Kafkas UniversityBezmiâlem Vakıf ÜniversitesiArdahan UniversityBiotechnology InstituteAtatürk University
PT

About

Pelin Tokalı is an author at Kafkas University specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

150

2

Biochemistry

3

3

150

3

Pharmacology

3

3

150

4

Natural Sciences

2

2

125

5

Diabetes

1

1

25

Pelin Tokalı

×

7

Publications

223

Citations

7

H-Index

YearCitations

Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors

Yeliz Demir, Feyzi Sinan Tokalı, Erbay Kalay,

Molecular Diversity

2022

85

Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies

Feyzi Sinan Tokalı, Halil Şenol, Şeyma Ateşoğlu,

Journal of Molecular Structure

2024

40

Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications

Feyzi Sinan Tokalı, Yeliz Demir, Halil Şenol,

Journal of Molecular Liquids

2025

25

Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complications

Feyzi Sinan Tokalı, Yeliz Demir, Şeyma Ateşoğlu,

Bioorganic & Medicinal Chemistry

2025

23

New Quinazolin‐4(3 <i>H</i> )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches

Feyzi Sinan Tokalı, Yeliz Demir, Pelin Tokalı,

Journal of Biochemical and Molecular Toxicology

2025

18

Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality

Pelin Tokalı, Yeliz Demir, Furkan Çakır,

Bioorganic Chemistry

2025

17

Quinazolin‐4(3<i>H</i>)‐One‐Based New Glitazones as Dual Inhibitors of α‐Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications

Feyzi Sinan Tokalı, Yeliz Demir, Şeyma Ateşoğlu,

Archiv der Pharmazie

2025

15

Page 1